retatrutide weight loss efficacy Eli Lilly's shows promising results in phase 3 trial Weight loss with retatrutide as

Just as GLP-1 in the body naturally does, GLP-1 medications work by: Stimulating insulin secretion, which allows cells to take up sugar Inhibiting the release of glucagon , which helps lower blood sugar levels Slowing stomach emptying, which can help prevent a post-meal sugar spike , as sugar from food is released more slowly into the bloodstream Increase how full you feel after eating Along with blood sugar management, these medications are also beneficial for weight management and reducing the risk of heart and kidney problems

However, persistent nausea throughout the day, nausea that interferes with eating or daily activities, or nausea accompanied by frequent vomiting suggests the dose exceeds your current tolerance

We have observed by all objective measures a significant reduction in lymphedema and the elimination of compression in the case presented as a direct result of GLP-1 RA

n338, 48 weeks), retatrutide produced a least-squares-mean body-weight reduction of about 24% at the 12 mg dose versus roughly 2% for placebo

In animal models, findings suggest stronger responses in obese specimens compared to lean ones